Calpain: a new matrix proteinase? by Shimizu, Katsuji
Bio Medical Reviews 1: 69-72 (1992) Bulgarian - American Center, Varna, Bulgaria 
Editor: G.N. Chaldakov 
  
CALPAIN: A NEW MATRIX PROTEINASE ? 
Katsuji Shimizu 





• Calpain, originally considered to be an intracellular 
proteinase, was demonstrated to be present extracellularly in 
growth cartilage of Wistar rat and also in synoval fluids of 
osteoarthritic patients. Proteoglycan-degrading proteolytic 
activities of calpain were demonstrated in vitro and in 
osteoarthritic synovial fluid. These data plus some recent 
reports of other investigators suggest that calpain-calpastatin 
system may have an important role in the metabolism of the 
extracellular matrix, although the pathways of exterruilization 
of these intracellular proteinase remain unclarified. 
INTRODUCTION 
• The enzyme capable of degrading macromolecules 
in extracellular matrix in the connective tissue is called 
matrix proteinase. The matrix proteinase is involved in 
matrix remodeling in which certain important biological 
phenomena take place. Such phenomena include: (I) 
Emigration of inflammatory cells out of blood vessels, 
through the basement membrane and underlying loose 
connective tissue, (II) Migration and proliferation of 
microvascular endothelial cells and fibroblasts during 
neovasculariza-tion, (III) Editing of excess matrix compo- 
nents during rapid connective tissue synthesis and assem- 
bly, (IV) Removal of obsolete matrix components from 
migration, signaling and assembly pathways, (V) Break- 
down of connective tissue components coupled to synthe- 
sis during tissue expansion and growth, (VI) Destruction 
of extracellular matrix during inflammation, activation of 
connective tissue cells, and fibrosis. (1) The matrix protei- 
nase is known to act as a lysosomal enzyme like cathepsin 
D on proteins taken up by endocytosis, or as a secretory 
proteinase like collagenase on extracellular matrix. (1) 
Calpain, also known by the name of CANP (cal- 
cium-activated neutral proteinase), is a calcium-depen- 
dent neutral cysteine proteinase. There are two types of 
calpain depending on the difference in Ca2+ requirements 
during its activation: calpain I which is activated by low 
concentration of Ca2+ (|aM) and calpain II which is acti- 
vated by high concentration of Ca2+ (mM). The presence 
of calpastatin, a specific inhibitor protein, has been also 
uncovered. (2) So far, calpain has been known as an 
intracellular proteinase. (3,4) Our recent investigation, 
however, has suggested that calpain may also function as 
a matrix proteinase capable of degrading cartilage 
proteoglycan. 
Calpain and calpastatin in calcifying zone of 
growth cartilage (5,6) 
In growth cartilage, the cartilage is calcified and 
new bone is formed by the process of endochondral 
ossification. Endocondral ossification is an important 
mechanism observed in the process of formation of most 
of the bones of the body such as bones in the extremities 
and spine. Morphologically, the growth cartilage consist of 
several layers: resting zone, proliferating zone, hypertro- 
phic zone, calcifying zone and the bone tissue of metaphysis 
in that order from cartilage to bone side. In the hypertro- 
phic and calcifying zones, some proteinases have been 
found (7), suggesting their involvement in the calcification 
mechanism. It is presumed that proteoglycan accounting 
for most of the matrix of cartilage has the ability to bind to 
calcium and suppress calcification. In the calcifying zone, 
the proteoglycan, affected by action of proteinases, under- 
goes deformation, thus allowing calcification to progress 
(8). 
Calpain, a proteinase which acts at neutral pH, is 
activated according to the concentration of calcium ion. If 
calpain is present in the calcifying zone of growth cartilage, 
  
  
and has proteoglycan-degrading activity, progress in calci- 
fication will accompany an elevation of calcium concen- 
tration, followed by activation of calpain, degradation of 
proteogycan, discharge of calcium and activation of calpain 
in that sequence, thus forming a vicious cycle toward cal- 
cification. The current study was designed to elucidate this 
presumption. 
Of knee joints collected from newborn and 3-day- 
old Wistar rats, growth cartilages of distal femur and 
proximal tibia were stained by an immunohistochemical 
technique. With the use of rabbit antiserum monospecific 
to the heavy subunit (80 kDa) of calpain I and II, the 
distribution of calpain was examined by the peroxidase 
method. In the epiphyseal cartilage of the rat, positive 
staining with anticalpain II antibody was observed in 
hypertrophic cartilage cells as well as in the surrounding 
cartialage matrix. In the resting zone, hypertrophic zone 
and metaphysis, however, positive staining was not ob- 
served. Positive staining with anticalpain I antibody was 
also not observed in any of the zones. With homogenates 
of metaphyseal cartilage obtained from the same 3-day- 
old Wistar rats, semicrude calpain was purified by DEAE- 
cellulose chromatography using caseinolytic activity as a 
parameter. 
Peak fractions containing caseinolytic activity were 
run on an SDS-polyacrylamide gel, and identification was 
done by immunoblotting using the antiserum identical to 
that used in the immmunohistochemical staining. From 
these homogenates, calpain was able to be biochemically 
detected. Findings from such immunohistochemical and 
biochemical examinations suggested the presence of calpain 
in hypertrophic chondrocytes and surrounding cartilage 
matrix of growth cartilage. Calpain, with its cartilage 
proteoglycan-degrading activity, which will be described 
in the following section, could be considered as one of the 
proteinases taking part in calcification of growth cartilage. 
Degradation of cartilage proteoglycan by calpain 
(9) 
The ability of calpain to degrade proteoglycan was 
examined with the use of calpain II extracted from growth 
cartilage or the kidney of rats and swine, and proteoglycan 
from articular cartilage of swine (proteoglycan monomer, 
proteoglycan aggregate and link protein (10) as substrates. 
These substances were further examined for changes in 
molecular size with the combined use of Sepharose 2B gel 
filtration chromatography, sucrose density gradient ultra- 
centrifugation and agarose polyacrylamide gel electro- 
phoresis. Findings were summarized as follows: (I) De- 
crease of molecular size was observed in proteoglycan 
monomers, proteoglycan aggregates and link proteins at 
neutral pH and calcium dependently with trace amount of 
the enzyme. (II) An inhibitory study confirmed that the 
above-mentioned effects were produced by calpain. (Ill) 
Besides such decrease of molecular size of proteoglycan 
monomers, observed were effects on molecular functions 
of proteoglycan, including disappearance of the abillity to 
reaggregate with hyaluronic acid. 
Calpain and calpastatin of synovial fluids of 
osteoarthritis (11) 
Once calpain was found to have a strong effect on 
degradation of cartilage proteoglycan, our interest shifted 
to whether calpain and calpastatin are present in synovial 
fluids or not. Because if calpain activity can be observed 
in synovial fluids, (I) the matrix of articular cartilage, 
which consists mostly of proteoglycan, would come in 
contact with calpain, thus possibly causing calpain to take 
part in degradation of the matrix of articular cartilage, and 
(II) an extracellular presence of calpain would be proved. 
Synovial fluid of ossteoarthritis was selected for the 
material to prove the extracellular presence of calpain in 
synovial fluid, because the use of synovial fluid obtained 
from subjects with rheumatoid arthritis which is rich in 
cellularity would not be proper for this purpose. Cellular- 
ity of the synovial fluid of osteoarthritis is known to be 
poor. We nevertheless examined the activity of the syno- 
vial fluid which had been further processed by filtration so 
as to prevent contamination by calpain and calpastatin 
from cellular component. By passing a linear gradient of 
sodium chloride through the synovial fluids absorbed to 
DEAE-cellulose, peaks of caseinolytic activity were ob- 
served at the positions of 150 and 300 mM. The inhibitor 
study and immunoblotting using monospecific antiserum 
proved these peak fractions to be calpain I and II, respec- 
tively. With the use of peak fractions of calpain I and II 
obtained from the synovial fluids by DEAE-cellulose 
chromatography, cartilage proteoglycan-degrading activ- 
ity was assayed: this activity was proved to be subjected to 
a nearly 100 % inhibition by E64 (a cystein proteinase 
inhibitor) and calpastatin (a specific inhibitor of calpain). 
Calpastatin was observed as a heat-stable calpain inhibitor 
at the position of 120 mM sodium chloride concentration 
on DEAE-cellulose chromatography of synovial fluids, 
and identified by immunoblotting using anticalpain anti- 
body. Of synovial fluid samples used in the curent study, 
calpain I was superior to calpain II in 6 samples in which 
quantitative assay could be carried out, and the quantity of 
inhibitor activity was superior to the total quantities of 
activity of 2 calpains therefore, the total activity of synovial 
fluids, the inhibitor was quantitatively superior. Calpain 
and calpastatin were found to be present in synovial fluids 
of osteoarthritis while remaining active extracellularly. 
A study recently published by other investigators 
also found calpain and calpastatin to be present in synovial 
fluids of rheumatoid arthritis. (12) Although there is a 
problem that if the balance of the calpain-calpastatin 
system is inclined to degradation or inhibition at the 
cartilage in osteoarthritis and rheumatoid arthritis, the 
matrix of articular cartilage consisting mostly of 
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proteoglycan would be in contact with the proteoglycan 
degrading activity-possessing calpain. Therefore, it is highly 
possible that calpain is involved in degeneration of articu- 
lar cartilage in such diseases. Further investigations would 
be required on changes in calpain and calpastatin of 
synovial fluids in various articular diseases. 
So far, two types of matrix proteinases have been 
known: proteinases which are secreted outside the cell 
throgh the Golgi body, such as collagenase, and lysosomal 
enzymes (a typical example is cathepsin D). These protei- 
nases secreted from the inside to the outside of the cell are 
known, in general, to have signal peptide which deter- 
mines transportation pathway between intracellular 
compartmens. Calpain is not a. lysosomal enzyme, and 
signal peptide is not contained either in calpain or in cal- 
pastatin.(13,14,15,16,17,18) Also known is the presence 
of proteins such as interleukin 1, which has no signal 
peptide, yet exerts its effects after moving outside the cell. 
(19) The pathway which interleukin 1 takes to come out of 
the cell without the help of signal peptide remains un- 
solved. Yet it is believed that during its move from the cell, 
the decrease of molecular size of interleukin 1 takes place 
simultaneously^ 19) It is unknown whether calpain and 
interleukin 1 share a common mechanism of secretion or 
not. 
Calpains have been generally known as intracellu- 
lar proteinases and catalyse selective but limited proteo- 
lytic modification of proteins. Findings from the current 
study suggested that calpain is present with an extracellu- 
lar activity, and it has an extracellular role of proteoglycan- 
degrading activity. Some previous studies have demon- 
strated an extracellular localization of calpain in the 
skeletal muscle after sciatic denervation or starvation of 
rats by immunogold electronmicroscopy.(20) Although 
the pathway which calpain takes to move out of the cell is 
not known yet, it would be encouraging to carry out further 
studies on calpain because of its provision of such proper- 
ties of matrix proteinase that it is present outside the cell 
in possession of enzyme activity and can degrade matrix 
proteoglycan. 
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